Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application
Open Access
- 23 February 2020
- Vol. 12 (2), 516
- https://doi.org/10.3390/cancers12020516
Abstract
Malignant gliomas are heterogeneous neoplasms. Glioma stem-like cells (GSCs) are undifferentiated and self-renewing cells that develop and maintain these tumors. These cells are the main population that resist current therapies. Genomic and epigenomic analyses has identified various molecular subtypes. Bone morphogenetic protein 4 (BMP4) reduces the number of GSCs through differentiation and induction of apoptosis, thus increasing therapeutic sensitivity. However, the short half-life of BMP4 impedes its clinical application. We previously reviewed BMP4 signaling in central nervous system development and glioma tumorigenesis and its potential as a treatment target in human gliomas. Recent advances in understanding both adult and pediatric malignant gliomas highlight critical roles of BMP4 signaling pathways in the regulation of tumor biology, and indicates its potential as a therapeutic molecule. Furthermore, significant progress has been made on synthesizing BMP4 biocompatible delivery materials, which can bind to and markedly extend BMP4 half-life. Here, we review current research associated with BMP4 in brain tumors, with an emphasis on pediatric malignant gliomas. We also summarize BMP4 delivery strategies, highlighting biocompatible BMP4 binding peptide amphiphile nanostructures as promising novel delivery platforms for treatment of these devastating tumors.Funding Information
- Foundation for the National Institutes of Health (P50CA221747-01A1)
This publication has 81 references indexed in Scilit:
- Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survivalJournal of Translational Medicine, 2013
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusionNeuro-Oncology, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Emerging peptide nanomedicine to regenerate tissues and organsJournal of Internal Medicine, 2009
- IDH1andIDH2Mutations in GliomasThe New England Journal of Medicine, 2009
- Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivoGene Therapy, 2008
- Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Pathway Inhibits Differentiation of Glioblastoma-Initiating CellsCancer Cell, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006